TCH-AML001 | AML001 | Acute myeloid leukemia | White | 1.33 | Male | De Novo | 405200 | 0 | No | 3 | | 47,XY,+8[20].ish
ins(10;11)(p1?3;q23q23)(10pter+,wcp10+,wcp11+,5'MLL+;wcp11+,
5'MLL-,3'MLL+,11qter+) | 90 | 2CDA,AAML1031 ADE10,ADE8,AE,Erwinia,HDAC,Ida,MTX,Multiple intensive regimens,PEG-asp,VCR,dexamethasone |
TCH-AML002 | AML002 | Acute myeloid leukemia | Black or African American | 20.04 | Female | Relapse | Unknown | Unknown | No | Unknown | | t(7;21), -17 | | Cytarabine,Fludarabine,Idarubicin,azacitidine,clo,decitabine,thiotepa,topotecan,venetoclax,venetoclax then DLI,vinorelbine |
TCH-AML003 | AML003 | t-Acute myeloid leukemia | White,Hispanic or Latino | 7.12 | Male | De Novo | 63 | 0 | No | 2 | FLT3 Alteration | 46,XY,t(11;19)(q23;p13.1)[20] | 80 | FLAG,TVTC,Vyxeos,decitabine,vorinostat |
TCH-AML004 | AML004 | Acute myeloid leukemia | White,Hispanic or Latino | 1.16 | Male | De Novo | 11450 | 2 | No | 1 | IDH2 | 46,XY,der(21)t(1;21)(q25;q22)[9]/46,XY[11] | 25 | ADE10,ADE8,Decitabine,Enasidanib,FLAG,Vorino,Vyxeos |
TCH-AML005a | AML005 | Acute myeloid leukemia | White,Hispanic or Latino | 16.7 | Male | De Novo | 348480 | 4 | No | 3 | RAS pathway | 47,XY,del(11)(q23q25),+21[20]; t(6;11) | 97 | ADE10,Azacitidine,Cytarabine,Flud,Stem Cell Transplant |
TCH-AML005b | AML005 | Acute myeloid leukemia | White,Hispanic or Latino | 16.7 | Male | Residual Disease | 348480 | 4 | No | 3 | RAS pathway | 47,XY,del(11)(q23q25),+21[20]; t(6;11) | 97 | ADE10,Azacitidine,Cytarabine,Flud,Stem Cell Transplant |